This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes
Yahoo Finance · 2 days ago
Open | 145.55 |
High | 148.87 |
Low | 145.55 |
Mkt Cap | 14.02B |
P/E (TTM) | 353.20 |
Div & Yield | N/A & N/A |
Prev. Close | 146.35 |
52 Wk. Low | 55.25 |
52 Wk. High | 173.25 |
Related stocks
Biopharmaceutical company
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 413.46M | 63.10% ▲ |
Net Income | 36.12M | - |
Diluted EPS | 0.37 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.02 | - |
Q1 2024 | -$0.07 | $0.37 |
Q4 2023 | $0.01 | $0.47 |
S&P 500^GSPC | 5,573.45+9.04 (+0.16%) |
Dow 30^DJI | 40,454.84+39.40 (+0.10%) |
Nasdaq^IXIC | 18,024.94+17.37 (+0.10%) |
333.55+12.89% | |
65.68+1.40% | |
46.55-6.07% |